+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Europe Vendor Neutral Archive & PACS Market Size, Share & Trends Analysis Report By Product Type, By Vendor Type, By Deployment, By End User, By Application, By Modality, By Country and Growth Forecast, 2024 - 2031

  • PDF Icon

    Report

  • 216 Pages
  • September 2024
  • Region: Europe
  • Marqual IT Solutions Pvt. Ltd (KBV Research)
  • ID: 6010198
The Europe Vendor Neutral Archive (VNA) & PACS Market is expected to witness market growth of 8.9% CAGR during the forecast period (2024-2031).

The Germany market dominated the Europe Vendor Neutral Archive (VNA) & PACS Market by Country in 2023, and is expected to continue to be a dominant market till 2031; thereby, achieving a market value of USD561.3 million by 2031. The UK market is exhibiting a CAGR of 8.3% during 2024-2031. Additionally, the France market would experience a CAGR of 9.8% during 2024-2031.



Both VNA and PACS systems can integrate various imaging modalities, such as CT scans, MRIs, X-rays, and ultrasounds. This multimodal data integration guarantees that various imaging techniques are stored uniformly, facilitating comprehensive analysis and comparison. It enhances diagnostic accuracy by providing a holistic view of a patient's imaging data.

VNA and PACS systems are crucial in enabling remote diagnostics and telemedicine services. They allow radiologists and other healthcare professionals to access and interpret imaging data from remote locations, supporting teleradiology and telemedicine consultations. This capability is especially beneficial in rural or underserved areas with limited access to specialized diagnostic services. VNA and PACS systems serve as valuable resources for research and educational purposes.

The expansion of the healthcare sector in Germany is significantly influencing the vendor neutral archive (VNA) and PACS market. With an impressive economic footprint of EUR 775 billion, accounting for approximately 12% of the nation's GDP, Germany’s healthcare system is one of the largest in Europe, creating a robust demand for advanced medical imaging solutions and data management technologies. A notable component of this digital transformation is the government's allocation of €1.67 billion under the National Recovery and Resilience Program (NRRP) for electronic medical records (EMR) and e-health technology infrastructure.

With 35% of the population currently utilizing EMR systems across 21 regions, the need for efficient data management and interoperability becomes paramount. VNA solutions enable healthcare providers to store, manage, and share medical imaging data from various sources in a standardized format, ensuring seamless access to patient information. Therefore, the expansion of Germany's healthcare sector and rising digitalization in Italy’s healthcare is fostering a conducive environment for the growth of the market.

Based on Product Type, the market is segmented into VNA (Multi-Department VNA, Department VNA, and Multi-Site VNA) and PACS (Multi-Department PACS, Department PACS, and Multi-Site PACS). Based on Vendor Type, the market is segmented into Independent Vendor and Third-party Vendor. Based on Deployment, the market is segmented into On-Premise, Cloud-Based, and Hybrid Model. Based on End User, the market is segmented into Hospitals & Clinics, Diagnostic Centers, and Others.

List of Key Companies Profiled

  • Hyland Software, Inc.
  • GE HealthCare Technologies, Inc.
  • Koninklijke Philips N.V.
  • Siemens Healthineers AG (Siemens AG)
  • Fujifilm Holdings Corporation
  • IBM Corporation
  • Carestream Health, Inc. (Onex Corporation)
  • Novarad Enterprise Healthcare Solutions
  • Canon, Inc. (Canon Medical Systems Corporation)
  • INFINITT Healthcare Co. Ltd.

Market Report Segmentation

By Product Type

  • VNA
  • Multi-Department VNA
  • Department VNA
  • Multi-Site VNA
  • PACS
  • Multi-Department PACS
  • Department PACS
  • Multi-Site PACS

By Vendor Type

  • Independent Vendor
  • Third-party Vendor

By Deployment

  • On-Premise
  • Cloud-Based
  • Hybrid Model

By End User

  • Hospitals & Clinics
  • Diagnostic Centers
  • Others

By Application

  • Cardiology
  • Orthopedic
  • Oncology
  • Neurology
  • Obstetrics & Gynecology
  • Others

By Modality

  • Computed Tomography
  • Mammography
  • MRI
  • Ultrasound
  • X-Rays
  • PET

By Country

  • Germany
  • UK
  • France
  • Russia
  • Spain
  • Italy
  • Rest of Europe

Table of Contents

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Vendor Neutral Archive (VNA) & PACS Market, by Product Type
1.4.2 Europe Vendor Neutral Archive (VNA) & PACS Market, by Vendor Type
1.4.3 Europe Vendor Neutral Archive (VNA) & PACS Market, by Deployment
1.4.4 Europe Vendor Neutral Archive (VNA) & PACS Market, by End User
1.4.5 Europe Vendor Neutral Archive (VNA) & PACS Market, by Application
1.4.6 Europe Vendor Neutral Archive (VNA) & PACS Market, by Modality
1.4.7 Europe Vendor Neutral Archive (VNA) & PACS Market, by Country
1.5 Methodology for the research
Chapter 2. Market at a Glance
2.1 Key Highlights
Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
3.2.3 Market Opportunities
3.2.4 Market Challenges
Chapter 4. Competition Analysis - Global
4.1 Cardinal Matrix
4.2 Recent Industry Wide Strategic Developments
4.2.1 Partnerships, Collaborations and Agreements
4.2.2 Product Launches and Product Expansions
4.2.3 Acquisition and Mergers
4.3 Market Share Analysis, 2023
4.4 Top Winning Strategies
4.4.1 Key Leading Strategies: Percentage Distribution (2020-2024)
4.4.2 Key Strategic Move: (Partnerships, Collaborations & Agreements : 2020, Aug - 2024, Feb) Leading Players
4.5 Porter Five Forces Analysis
Chapter 5. Europe Vendor Neutral Archive (VNA) & PACS Market by Product Type
5.1 Europe VNA Market by Country
5.2 Europe Vendor Neutral Archive (VNA) & PACS Market by VNA Type
5.2.1 Europe Multi-Department VNA Market by Country
5.2.2 Europe Department VNA Market by Country
5.2.3 Europe Multi-Site VNA Market by Country
5.3 Europe PACS Market by Country
5.4 Europe Vendor Neutral Archive (VNA) & PACS Market by PACS Type
5.4.1 Europe Multi-Department PACS Market by Country
5.4.2 Europe Department PACS Market by Country
5.4.3 Europe Multi-Site PACS Market by Country
Chapter 6. Europe Vendor Neutral Archive (VNA) & PACS Market by Vendor Type
6.1 Europe Independent Vendor Market by Country
6.2 Europe Third-party Vendor Market by Country
Chapter 7. Europe Vendor Neutral Archive (VNA) & PACS Market by Deployment
7.1 Europe On-Premise Market by Country
7.2 Europe Cloud-Based Market by Country
7.3 Europe Hybrid Model Market by Country
Chapter 8. Europe Vendor Neutral Archive (VNA) & PACS Market by End User
8.1 Europe Hospitals & Clinics Market by Country
8.2 Europe Diagnostic Centers Market by Country
8.3 Europe Others Market by Country
Chapter 9. Europe Vendor Neutral Archive (VNA) & PACS Market by Application
9.1 Europe Cardiology Market by Country
9.2 Europe Orthopedic Market by Country
9.3 Europe Oncology Market by Country
9.4 Europe Neurology Market by Country
9.5 Europe Obstetrics & Gynecology Market by Country
9.6 Europe Others Market by Country
Chapter 10. Europe Vendor Neutral Archive (VNA) & PACS Market by Modality
10.1 Europe Computed Tomography Market by Country
10.2 Europe Mammography Market by Country
10.3 Europe MRI Market by Country
10.4 Europe Ultrasound Market by Country
10.5 Europe X-Rays Market by Country
10.6 Europe PET Market by Country
Chapter 11. Europe Vendor Neutral Archive (VNA) & PACS Market by Country
11.1 Germany Vendor Neutral Archive (VNA) & PACS Market
11.1.1 Germany Vendor Neutral Archive (VNA) & PACS Market by Product Type
11.1.1.1 Germany Vendor Neutral Archive (VNA) & PACS Market by VNA Type
11.1.1.2 Germany Vendor Neutral Archive (VNA) & PACS Market by PACS Type
11.1.2 Germany Vendor Neutral Archive (VNA) & PACS Market by Vendor Type
11.1.3 Germany Vendor Neutral Archive (VNA) & PACS Market by Deployment
11.1.4 Germany Vendor Neutral Archive (VNA) & PACS Market by End User
11.1.5 Germany Vendor Neutral Archive (VNA) & PACS Market by Application
11.1.6 Germany Vendor Neutral Archive (VNA) & PACS Market by Modality
11.2 UK Vendor Neutral Archive (VNA) & PACS Market
11.2.1 UK Vendor Neutral Archive (VNA) & PACS Market by Product Type
11.2.1.1 UK Vendor Neutral Archive (VNA) & PACS Market by VNA Type
11.2.1.2 UK Vendor Neutral Archive (VNA) & PACS Market by PACS Type
11.2.2 UK Vendor Neutral Archive (VNA) & PACS Market by Vendor Type
11.2.3 UK Vendor Neutral Archive (VNA) & PACS Market by Deployment
11.2.4 UK Vendor Neutral Archive (VNA) & PACS Market by End User
11.2.5 UK Vendor Neutral Archive (VNA) & PACS Market by Application
11.2.6 UK Vendor Neutral Archive (VNA) & PACS Market by Modality
11.3 France Vendor Neutral Archive (VNA) & PACS Market
11.3.1 France Vendor Neutral Archive (VNA) & PACS Market by Product Type
11.3.1.1 France Vendor Neutral Archive (VNA) & PACS Market by VNA Type
11.3.1.2 France Vendor Neutral Archive (VNA) & PACS Market by PACS Type
11.3.2 France Vendor Neutral Archive (VNA) & PACS Market by Vendor Type
11.3.3 France Vendor Neutral Archive (VNA) & PACS Market by Deployment
11.3.4 France Vendor Neutral Archive (VNA) & PACS Market by End User
11.3.5 France Vendor Neutral Archive (VNA) & PACS Market by Application
11.3.6 France Vendor Neutral Archive (VNA) & PACS Market by Modality
11.4 Russia Vendor Neutral Archive (VNA) & PACS Market
11.4.1 Russia Vendor Neutral Archive (VNA) & PACS Market by Product Type
11.4.1.1 Russia Vendor Neutral Archive (VNA) & PACS Market by VNA Type
11.4.1.2 Russia Vendor Neutral Archive (VNA) & PACS Market by PACS Type
11.4.2 Russia Vendor Neutral Archive (VNA) & PACS Market by Vendor Type
11.4.3 Russia Vendor Neutral Archive (VNA) & PACS Market by Deployment
11.4.4 Russia Vendor Neutral Archive (VNA) & PACS Market by End User
11.4.5 Russia Vendor Neutral Archive (VNA) & PACS Market by Application
11.4.6 Russia Vendor Neutral Archive (VNA) & PACS Market by Modality
11.5 Spain Vendor Neutral Archive (VNA) & PACS Market
11.5.1 Spain Vendor Neutral Archive (VNA) & PACS Market by Product Type
11.5.1.1 Spain Vendor Neutral Archive (VNA) & PACS Market by VNA Type
11.5.1.2 Spain Vendor Neutral Archive (VNA) & PACS Market by PACS Type
11.5.2 Spain Vendor Neutral Archive (VNA) & PACS Market by Vendor Type
11.5.3 Spain Vendor Neutral Archive (VNA) & PACS Market by Deployment
11.5.4 Spain Vendor Neutral Archive (VNA) & PACS Market by End User
11.5.5 Spain Vendor Neutral Archive (VNA) & PACS Market by Application
11.5.6 Spain Vendor Neutral Archive (VNA) & PACS Market by Modality
11.6 Italy Vendor Neutral Archive (VNA) & PACS Market
11.6.1 Italy Vendor Neutral Archive (VNA) & PACS Market by Product Type
11.6.1.1 Italy Vendor Neutral Archive (VNA) & PACS Market by VNA Type
11.6.1.2 Italy Vendor Neutral Archive (VNA) & PACS Market by PACS Type
11.6.2 Italy Vendor Neutral Archive (VNA) & PACS Market by Vendor Type
11.6.3 Italy Vendor Neutral Archive (VNA) & PACS Market by Deployment
11.6.4 Italy Vendor Neutral Archive (VNA) & PACS Market by End User
11.6.5 Italy Vendor Neutral Archive (VNA) & PACS Market by Application
11.6.6 Italy Vendor Neutral Archive (VNA) & PACS Market by Modality
11.7 Rest of Europe Vendor Neutral Archive (VNA) & PACS Market
11.7.1 Rest of Europe Vendor Neutral Archive (VNA) & PACS Market by Product Type
11.7.1.1 Rest of Europe Vendor Neutral Archive (VNA) & PACS Market by VNA Type
11.7.1.2 Rest of Europe Vendor Neutral Archive (VNA) & PACS Market by PACS Type
11.7.2 Rest of Europe Vendor Neutral Archive (VNA) & PACS Market by Vendor Type
11.7.3 Rest of Europe Vendor Neutral Archive (VNA) & PACS Market by Deployment
11.7.4 Rest of Europe Vendor Neutral Archive (VNA) & PACS Market by End User
11.7.5 Rest of Europe Vendor Neutral Archive (VNA) & PACS Market by Application
11.7.6 Rest of Europe Vendor Neutral Archive (VNA) & PACS Market by Modality
Chapter 12. Company Profiles
12.1 Hyland Software, Inc.
12.1.1 Company Overview
12.1.2 Recent strategies and developments
12.1.2.1 Partnerships, Collaborations, and Agreements
12.1.2.2 Product Launches and Product Expansions
12.2 GE HealthCare Technologies, Inc.
12.2.1 Company Overview
12.2.2 Financial Analysis
12.2.3 Segmental and Regional Analysis
12.2.4 Research & Development Expenses
12.2.5 Recent strategies and developments
12.2.5.1 Partnerships, Collaborations, and Agreements
12.2.6 SWOT Analysis
12.3 Koninklijke Philips N.V.
12.3.1 Company Overview
12.3.2 Financial Analysis
12.3.3 Segmental and Regional Analysis
12.3.4 Research & Development Expense
12.3.5 Recent strategies and developments
12.3.5.1 Partnerships, Collaborations, and Agreements
12.3.6 SWOT Analysis
12.4 Siemens Healthineers AG (Siemens AG)
12.4.1 Company Overview
12.4.2 Financial Analysis
12.4.3 Segmental and Regional Analysis
12.4.4 Research & Development Expense
12.4.5 Recent strategies and developments
12.4.5.1 Partnerships, Collaborations, and Agreements
12.4.6 SWOT Analysis
12.5 Fujifilm Holdings Corporation
12.5.1 Company Overview
12.5.2 Financial Analysis
12.5.3 Segmental and Regional Analysis
12.5.4 Research & Development Expenses
12.5.5 Recent strategies and developments
12.5.5.1 Product Launches and Product Expansions
12.5.5.2 Acquisition and Mergers
12.5.6 SWOT Analysis
12.6 IBM Corporation
12.6.1 Company Overview
12.6.2 Financial Analysis
12.6.3 Regional & Segmental Analysis
12.6.4 Research & Development Expenses
12.6.5 Recent strategies and developments
12.6.5.1 Product Launches and Product Expansions
12.6.6 SWOT Analysis
12.7 Carestream Health, Inc. (Onex Corporation)
12.7.1 Company Overview
12.7.2 SWOT Analysis
12.8 Novarad Enterprise Healthcare Solutions
12.8.1 Company Overview
12.8.2 Recent strategies and developments
12.8.2.1 Partnerships, Collaborations, and Agreements
12.8.2.2 Product Launches and Product Expansions
12.8.3 SWOT Analysis
12.9 Canon, Inc. (Canon Medical Systems Corporation)
12.9.1 Company Overview
12.9.2 Financial Analysis
12.9.3 Segmental and Regional Analysis
12.9.4 Research & Development Expenses
12.9.5 Recent strategies and developments
12.9.5.1 Partnerships, Collaborations, and Agreements
12.9.5.2 Product Launches and Product Expansions
12.9.6 SWOT Analysis
12.10. INFINITT Healthcare Co. Ltd.
12.10.1 Company Overview
12.10.2 Recent strategies and developments
12.10.2.1 Partnerships, Collaborations, and Agreements
12.10.2.2 Product Launches and Product Expansions
12.10.3 SWOT Analysis

Companies Mentioned

Some of the key companies in the Europe Vendor Neutral Archive (VNA) & PACS Market include:
  • Hyland Software, Inc.
  • GE HealthCare Technologies, Inc.
  • Koninklijke Philips N.V.
  • Siemens Healthineers AG (Siemens AG)
  • Fujifilm Holdings Corporation
  • IBM Corporation
  • Carestream Health, Inc. (Onex Corporation)
  • Novarad Enterprise Healthcare Solutions
  • Canon, Inc. (Canon Medical Systems Corporation)
  • INFINITT Healthcare Co. Ltd.

Methodology

Loading
LOADING...